Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
disease | 0.400 | None | 0.979 | 11 | 0 | 1991 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.400 | None | 0.932 | 8 | 0 | 1996 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.947 | 8 | 0 | 1989 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.979 | 6 | 0 | 1994 | 2020 | ||||||||
|
dihydropyrimidine dehydrogenase | 0.493 | 0.846 | 3.4E-22 |
|
disease | 0.400 | None | 0.965 | 5 | 0 | 1998 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.976 | 4 | 0 | 2002 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.700 | None | 0.983 | 4 | 0 | 1997 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway 2 | 0.582 | 0.654 | 1.00 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2008 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.600 | None | 0.963 | 3 | 0 | 1990 | 2020 | ||||||||
|
thymidine phosphorylase | 0.495 | 0.769 | 1.2E-04 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
Enah/Vasp-like | 0.729 | 0.308 | 1.00 |
|
disease | 0.520 | None | 1.000 | 2 | 0 | 2008 | 2015 | ||||||||
|
intercellular adhesion molecule 5 | 0.716 | 0.346 | 2.1E-03 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2008 | 2011 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.600 | None | 0.960 | 2 | 0 | 1990 | 2020 | ||||||||
|
protein tyrosine phosphatase receptor type D | 0.584 | 0.731 | 1.00 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 2008 | 2011 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2006 | 2019 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2006 | 2019 | ||||||||
|
secreted frizzled related protein 2 | 0.544 | 0.731 | 1.7E-03 |
|
disease | 0.400 | None | 0.963 | 2 | 0 | 2004 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.991 | 2 | 0 | 1992 | 2020 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.925 | 2 | 0 | 1999 | 2019 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
disease | 0.600 | None | 1.000 | 2 | 0 | 2008 | 2019 | ||||||||
|
gremlin 1, DAN family BMP antagonist | 0.508 | 0.808 | 0.47 |
|
disease | 0.500 | None | 0.957 | 2 | 0 | 2003 | 2019 | ||||||||
|
uridine monophosphate synthetase | 0.584 | 0.615 | 1.1E-04 |
|
disease | 0.330 | None | 1.000 | 2 | 0 | 2005 | 2013 | ||||||||
|
guanylate cyclase 1 soluble subunit alpha 2 | 0.792 | 0.192 | 0.31 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 2008 | 2011 | ||||||||
|
DNA polymerase delta 3, accessory subunit | 0.631 | 0.462 | 1.00 |
|
disease | 0.420 | None | 1.000 | 2 | 0 | 2012 | 2019 | ||||||||
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase | 0.502 | 0.808 | 2.2E-14 |
|
disease | 0.390 | None | 1.000 | 2 | 0 | 2002 | 2019 |